Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Boric acid + white soft paraffin is a topical antiseptic ointment developed and manufactured by NI-THE Pharmaceuticals. The formulation combines boric acid, which exerts mild antibacterial and antifungal effects, with white soft paraffin (petrolatum), which serves as an occlusive emollient base. The paraffin component creates a physical barrier on the skin's surface, promoting hydration and protecting minor wounds or irritations from environmental factors, while the boric acid helps prevent or treat minor dermatological infections. It is typically used for localized skin conditions requiring both protection and mild disinfection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on boric acid + white soft paraffin.